These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 16858161

  • 1. Flutamide in men with prostatic intraepithelial neoplasia: a randomized, placebo-controlled chemoprevention trial.
    Alberts SR, Novotny PJ, Sloan JA, Danella J, Bostwick DG, Sebo TJ, Blute ML, Fitch TR, Levitt R, Lieberman R, Loprinzi CL.
    Am J Ther; 2006; 13(4):291-7. PubMed ID: 16858161
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Flutamide reduced prostate cancer development and prostate stem cell antigen mRNA expression in high grade prostatic intraepithelial neoplasia.
    Zhigang Z, Wenlu S.
    Int J Cancer; 2008 Feb 15; 122(4):864-70. PubMed ID: 17957793
    [Abstract] [Full Text] [Related]

  • 4. Chemoprevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia (HGPIN): a systematic review and adjusted indirect treatment comparison.
    Cui K, Li X, Du Y, Tang X, Arai S, Geng Y, Xi Y, Xu H, Zhou Y, Ma W, Zhang T.
    Oncotarget; 2017 May 30; 8(22):36674-36684. PubMed ID: 28415774
    [Abstract] [Full Text] [Related]

  • 5. Prostate cancer diagnosis among men with isolated high-grade intraepithelial neoplasia enrolled onto a 3-year prospective phase III clinical trial of oral toremifene.
    Taneja SS, Morton R, Barnette G, Sieber P, Hancock ML, Steiner M.
    J Clin Oncol; 2013 Feb 10; 31(5):523-9. PubMed ID: 23295793
    [Abstract] [Full Text] [Related]

  • 6. Bilateral orchidectomy and flutamide versus orchidectomy alone in newly diagnosed patients with metastatic carcinoma of the prostate--an Australian multicentre trial.
    Zalcberg JR, Raghaven D, Marshall V, Thompson PJ.
    Br J Urol; 1996 Jun 10; 77(6):865-9. PubMed ID: 8705223
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Quality of life in advanced prostate cancer: results of a randomized therapeutic trial.
    Moinpour CM, Savage MJ, Troxel A, Lovato LC, Eisenberger M, Veith RW, Higgins B, Skeel R, Yee M, Blumenstein BA, Crawford ED, Meyskens FL.
    J Natl Cancer Inst; 1998 Oct 21; 90(20):1537-44. PubMed ID: 9790546
    [Abstract] [Full Text] [Related]

  • 9. A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?
    Gontero P, Marra G, Soria F, Oderda M, Zitella A, Baratta F, Chiorino G, Gregnanin I, Daniele L, Cattel L, Frea B, Brusa P.
    Prostate; 2015 Aug 01; 75(11):1177-86. PubMed ID: 25893930
    [Abstract] [Full Text] [Related]

  • 10. Dutasteride for the prevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia: results of a phase III randomized open-label 3-year trial.
    Milonas D, Auskalnis S, Skulcius G, Gudinaviciene I, Jievaltas M, Joniau S.
    World J Urol; 2017 May 01; 35(5):721-728. PubMed ID: 27644229
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Influence of irradiation and androgen ablation on prostatic intraepithelial neoplasia.
    Wheeler TM.
    Eur Urol; 1996 May 01; 30(2):261-4. PubMed ID: 8875209
    [Abstract] [Full Text] [Related]

  • 13. Phase IIA clinical trial to test the efficacy and safety of Toremifene in men with high-grade prostatic intraepithelial neoplasia.
    Steiner MS, Pound CR.
    Clin Prostate Cancer; 2003 Jun 01; 2(1):24-31. PubMed ID: 15046680
    [Abstract] [Full Text] [Related]

  • 14. Androgen deprivation therapy for prostate cancer chemoprevention: current status and future directions for agent development.
    Lieberman R.
    Urology; 2001 Aug 01; 58(2 Suppl 1):83-90. PubMed ID: 11502457
    [Abstract] [Full Text] [Related]

  • 15. Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma: flutamide versus diethylstilbestrol.
    Chang A, Yeap B, Davis T, Blum R, Hahn R, Khanna O, Fisher H, Rosenthal J, Witte R, Schinella R, Trump D.
    J Clin Oncol; 1996 Aug 01; 14(8):2250-7. PubMed ID: 8708714
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Interstitial pneumonitis related to flutamide monotherapy for prostate cancer.
    Nomura M, Sato H, Fujimoto N, Matsumoto T.
    Int J Urol; 2004 Sep 01; 11(9):798-800. PubMed ID: 15379950
    [Abstract] [Full Text] [Related]

  • 20. Expression of ERG protein, a prostate cancer specific marker, in high grade prostatic intraepithelial neoplasia (HGPIN): lack of utility to stratify cancer risks associated with HGPIN.
    He H, Osunkoya AO, Carver P, Falzarano S, Klein E, Magi-Galluzzi C, Zhou M.
    BJU Int; 2012 Dec 01; 110(11 Pt B):E751-5. PubMed ID: 23046279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.